Carol Greider, Johns Hopkins researcher and a winner of the Nobel prize last week for her work on telomeres, submits to a Q&A with the New York Times. Asked about the timing of this prize -- Greider has for years been shortlisted as a potential laureate -- she responded, "I think it’s clear now that the basic science we did is important to understanding cancers, some human genetic diseases and the age associated degenerative diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.